Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
- Congress This Week
- COVID-19 Public Health Emergency Extended through Mid-January
- New Executive Order Directs HHS to Leverage CMS Innovation Center to Improve Access to and Lower Drug Costs
- IRA Implementation Update
- Medicare 340B Payment Cut Ending for 2022
- Forthcoming Rules
- FDA Debates Removing Preterm Birth Preventive Drug From Market, Reigniting Criticisms of Accelerated Approval Pathway
- FDA Seeks Public Feedback on Distributed and Point-of-Care Drug Manufacturing
- Treasury Department Finalized Family Glitch Rule
- Medicare Open Enrollment Oct. 15 through Dec. 7
- FDA, CDC Green Light Omicron-Targeted Booster for Young Children; Vaccine Rates Remain Stagnant
- CMS Extends, Updates BPCI Advanced Model
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.